| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.01 | 0.8 |